FDA Issues its Strongest Warning on Anti-Malaria Drug Lariam
Lariam anti-malaria drug (Photo: James Gray King/Flickr)
The anti-malaria drug has been used for years by the military and by international travelers. Mefloquine, sold as Lariam in the US, must now carry a “black box” warning on its label because of the drug’s serious neurological and psychiatric side effects.
Dr. Remington Nevin, a former Army epidemologist who’s done extensive research on the drug’s side-effects—including depression, anxiety, nightmares, paranoia, delusions and hallucinations—helped persuade the FDA to issue the warning.
“Mefloquine belongs to a class of drugs known to be neurotoxic which is associated with permanent brain injury,” he says. “It remains licensed for use, but I think the latest warnings by the FDA will spell the demise of mefloquine among most travelers.”
Unfortunately, said Dr. Nevin, the drug is still being used by the US military but only as a “last resort.”
Lariam/Mefloquine has been blamed for causing a number of violent deaths.
“The military has had a hard time educating its medics and service members of the true dangers of the drug.”
The World is an independent newsroom. We’re not funded by billionaires; instead, we rely on readers and listeners like you. As a listener, you’re a crucial part of our team and our global community. Your support is vital to running our nonprofit newsroom, and we can’t do this work without you. Will you support The World with a gift today? Donations made between now and Dec. 31 will be matched 1:1. Thanks for investing in our work!